摘要
目的:观察纳米壳聚糖携带miR-29b表达质粒对大鼠肝星状细胞的转染效率和治疗效果。方法:制备载miR-29b表达质粒的纳米壳聚糖,并转染大鼠肝星状细胞,荧光显微镜和流式细胞仪观察转染效率,实时荧光定量RT-PCR分析Ⅰ型胶原α1链mRNA的表达水平。结果:紫外分光光度计分析纳米壳聚糖的载药率为91.56%。凝胶电泳阻滞实验显示纳米壳聚糖与质粒结合较好。纳米壳聚糖携带miR-29b表达质粒的转染效率为31.9%,脂质体的转染效率为35.1%,两者差别无统计学意义(P>0.05)。与对照组相比,纳米壳聚糖组和脂质体组Ⅰ型胶原α1链mRNA表达水平明显下降,分别为29%和32%,差别有统计学意义(P<0.05)。结论:纳米壳聚糖载体具有较高的转染效率,携带miR-29b具有较好的抗肝纤维化效果。我们的研究为肝纤维化基因治疗提供了一种新型载体。
Objective:To explore the transfection efficiency and antifibrotic effect of miR -29b expression plas- mid in transfecting cultured rat hepatic stellate cells (HSCs) with nanochitosan as carrier. Methods: Using nanoch- itosan as transfection reagents, miR -29b expression plasmid was transfected into HSCs. Transfection efficiency was observed under fluorescence microscope and flow cytometry. Collagen al (I) mRNA expression were analyzed by re- al -time RT- PCR. Results: UV spectrophotometric analysis indicated that loading efficiency of nanochitosan was 91.56%. Gel retardation experiments showed that nanochitosan and miR- 29b expression plasmid were well com- bined. Using nanochitosan and liposome as transfection reagents, the transfection efficiencies of miR -29b expres- sion plasmid were about 31.9% and 35.1%, respectively. There was no significant difference. Compared with the control group, Collagen otl(I) mRNA expressions in nanochitosan group and liposome group decreased remarkably, about 29% and 32%, respectively. There was statistical significance. Conclusion: Nanochitosan has a relatively high transfection efficiency. MiR- 29b expression plasmid transfected into HSCs using Nanochitosan demonstrated a good antifibrotic effect. The study provided a new vector for gene therapy of liver fibrosis.
出处
《中国卫生检验杂志》
北大核心
2013年第2期332-334,337,共4页
Chinese Journal of Health Laboratory Technology
基金
国家自然科学基金(81000176/H0317
81100292/H0317)
浙江省自然科学基金(Y2110634
Y2090326)
王宝恩肝纤维化研究基金(20100002)
温州市科技局(Y20110033
Y20100119)
浙江省"十二五"高校重点学科"危重病与灾害救援医学"